| JYHB2002753 | 磷酸芦可替尼片 | ruxolitinib phosphate | Tablet | Chemical Drugs | Supplementary Application | 2021-01-01 | Novartis Pharma Schweiz AG | Novartis Pharma Schweiz AG | Certificate Issued | 2021-03-22 | view |
| JYHB2002755 | 磷酸芦可替尼片 | ruxolitinib phosphate | Tablet | Chemical Drugs | Supplementary Application | 2021-01-01 | Novartis Pharma Schweiz AG | Novartis Pharma Schweiz AG | Certificate Issued | 2021-03-22 | view |
| JYHB2002252 | 艾曲泊帕乙醇胺片 | eltrombopag olamine | Tablet | Chemical Drugs | Supplementary Application | 2020-11-09 | Novartis Pharma Schweiz AG | Novartis Pharma Schweiz AG | In Review | 2020-11-07 | view |
| JYHB2002251 | 艾曲泊帕乙醇胺片 | eltrombopag olamine | Tablet | Chemical Drugs | Supplementary Application | 2020-11-09 | Novartis Pharma Schweiz AG | Novartis Pharma Schweiz AG | In Review | 2020-11-07 | view |
| JYHB2001548 | 磷酸芦可替尼片 | ruxolitinib phosphate | Tablet | Chemical Drugs | Supplementary Application | 2020-08-24 | Novartis Pharma Schweiz AG | Novartis Pharma Schweiz AG | Certificate Issued | 2020-11-17 | view |
| JYHB2001550 | 磷酸芦可替尼片 | ruxolitinib phosphate | Tablet | Chemical Drugs | Supplementary Application | 2020-08-24 | Novartis Pharma Schweiz AG | Novartis Pharma Schweiz AG | Certificate Issued | 2020-11-17 | view |
| JYHB2001549 | 磷酸芦可替尼片 | ruxolitinib phosphate | Tablet | Chemical Drugs | Supplementary Application | 2020-08-24 | Novartis Pharma Schweiz AG | Novartis Pharma Schweiz AG | Certificate Issued | 2020-11-17 | view |
| JYHB2001445 | 尼洛替尼胶囊 | nilotinib | Capsule | Chemical Drugs | Supplementary Application | 2020-08-21 | Novartis Pharma Schweiz AG | Novartis Pharma Schweiz AG | Certificate Issued | 2020-11-03 | view |
| JYHB2001444 | 尼洛替尼胶囊 | nilotinib | Capsule | Chemical Drugs | Supplementary Application | 2020-08-21 | Novartis Pharma Schweiz AG | Novartis Pharma Schweiz AG | Certificate Issued | 2020-11-03 | view |
| JYHB2001443 | 尼洛替尼胶囊 | nilotinib | Capsule | Chemical Drugs | Supplementary Application | 2020-08-21 | Novartis Pharma Schweiz AG | Novartis Pharma Schweiz AG | Certificate Issued | 2020-11-03 | view |
| JYHB2000988 | 艾曲泊帕乙醇胺片 | eltrombopag olamine | Tablet | Chemical Drugs | Supplementary Application | 2020-06-25 | Novartis Pharma Schweiz AG | Novartis Pharma Schweiz AG | Filed | 2020-06-29 | view |
| JYHB2000897 | 磷酸芦可替尼片 | ruxolitinib phosphate | Tablet | Chemical Drugs | Supplementary Application | 2020-06-19 | Novartis Pharma Schweiz AG | Novartis Pharma Schweiz AG | Filed | 2020-06-24 | view |
| JYHB2000837 | 尼洛替尼胶囊 | nilotinib | Capsule | Chemical Drugs | Supplementary Application | 2020-06-15 | Novartis Pharma Schweiz AG | Novartis Pharma Schweiz AG | Filed | 2020-06-19 | view |
| JYHB2000836 | 尼洛替尼胶囊 | nilotinib | Capsule | Chemical Drugs | Supplementary Application | 2020-06-15 | Novartis Pharma Schweiz AG | Novartis Pharma Schweiz AG | Filed | 2020-06-19 | view |
| JYHB2000838 | 尼洛替尼胶囊 | nilotinib | Capsule | Chemical Drugs | Supplementary Application | 2020-06-15 | Novartis Pharma Schweiz AG | Novartis Pharma Schweiz AG | Filed | 2020-06-19 | view |
| JYHB2000592 | 艾曲泊帕乙醇胺片 | eltrombopag olamine | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2020-05-15 | Novartis Pharma Schweiz AG | Novartis Pharma Schweiz AG | Filed | 2020-05-26 | view |
| JYHB2000526 | 艾曲泊帕乙醇胺片 | eltrombopag olamine | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2020-04-29 | Novartis Pharma Schweiz AG | Novartis Pharma Schweiz AG | Filed | 2020-05-12 | view |
| JYHB2000527 | 艾曲泊帕乙醇胺片 | eltrombopag olamine | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2020-04-29 | Novartis Pharma Schweiz AG | Novartis Pharma Schweiz AG | Filed | 2020-05-12 | view |
| JYHB2000524 | 注射用唑来膦酸浓溶液 | zoledronic acid | Injection | Chemical Drugs | Supplementary Application | 2020-04-28 | Novartis Pharma Schweiz AG | Novartis Pharma Schweiz AG | Filed | 2020-05-11 | view |
| JYHB2000359 | 尼洛替尼胶囊 | nilotinib | Capsule | Chemical Drugs | Supplementary Application | 2020-04-01 | Novartis Pharma Schweiz AG | Novartis Pharma Schweiz AG | Filed | 2020-04-13 | view |
